A Case Study & Report on Drug Related Adverse Effect Observed and Addressed during Optimal Therapy by Doctor of Pharmacy, in an Antiretroviral Therapy Ward of a Tertiary care teaching Hospital.
DOI:
https://doi.org/10.37591/rrjom.v8i1.248Abstract
In the present case study, a drug related adverse effect is observed and addressed during optimal therapy in Antiretroviral Therapy ward of Rajiv Gandhi Institute of Medical Sciences, Kadapa, Andhra Pradesh, India. As a part of Doctor of Pharmacy profession, Manasa Rekha has identified dose related adverse effect and have taken to the notice of Physician and monitored the dose of drug by using therapeutic drug monitoring parameters and have provided patient counseling to the concerned patient. By this case study and report it is concluded that in India, there is increased work load on physicians who are unable to look over overall healthcare services, hence here is a chance for Doctor of Pharmacy professionals to explore their clinical pharmacy services this can decrease work load over physicians which can improve the overall health care of society. So, there is urgent need of Doctor of Pharmacy services to Indian Hospitals, so it is the responsibility of Indian Government to provide a responsibility cadre to Indian Doctor of Pharmacy professionals as soon as possible in order to improve the medical care in India.
Keywords: Adverse effect, Anti-retroviral therapy ward, therapeutic drug monitoring, Doctor of Pharmacy, clinical pharmacy
Cite this Article
M. Manasa Rekha. A Case Study &Report on Drug Related Adverse Effect Observed and Addressed during Optimal Therapy by Doctor of Pharmacy, in an Antiretroviral Therapy Ward of a Tertiary care teaching Hospital. Research & Reviews: Journal of Medicine. 2018; 8(1): 1–5p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |